The story has been updated to include comments from the company's earnings call this morning.

NEW YORK (GenomeWeb) – Exact Sciences today said that its fourth quarter revenues grew 50 percent year over year. 

For the three months ended Dec. 31, 2014, the Madison, Wis.-based molecular diagnostics company reported revenues of $1.5 million, up from $1 million in Q4 2013 and even with the average analysts' estimate. 

All revenues in the recently completed quarter derived from laboratory services, while revenues from the year-ago period derived from license fees. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.